Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.96 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.96 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.96 |
| ▸ | APAF1 | O14727 | 1/20 | 0.96 |
| ▸ | NPC1 | O15118 | 1/20 | 0.96 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.96 |
| ▸ | MAPT | P10636 | 1/20 | 0.96 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.96 |
| ▸ | HTT | P42858 | 1/20 | 0.96 |
| ▸ | RAB9A | P51151 | 1/20 | 0.96 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.96 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.96 |
| ▸ | FDPS | P14324 | 16/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372300 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL34918 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL92681 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4061743 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2219975 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4066192 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL15535406 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2890408 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL899203 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5305358 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 865 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | claimed |
| CN-119059497-A | Process for the production of onium salts of bis (fluorosulfonyl) imide | 法国特种经营公司 | 2024-12-03 | — | — | CN | claimed |
| WO-2024078801-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| EP-4353760-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2024-04-17 | — | — | EP | claimed |
| CN-111836849-B | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | claimed |
| CN-114085425-B | Beta-crystal-form compound nucleating agent and application thereof | 宁波福天新材料科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-115141480-A | Antistatic thermoplastic polyurethane and preparation method and application thereof | 上海朗亿功能材料有限公司 | 2022-10-04 | — | — | CN | claimed |
| EP-3512905-B1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2022-08-24 | — | — | EP | claimed |
| CN-114057615-B | High-temperature-resistant polymerizable antibacterial agent, preparation thereof and application thereof in synthesis of antibacterial polyester | 浙江大学 | 2022-08-02 | — | — | CN | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| EP-1717243-A1 | Uses of cationic salts for polynucleotide synthesis | Agilent Technologies, Inc. (US) | 2006-11-02 | — | — | EP | claimed |
| WO-2006077082-A1 | METHOD FOR SEALING ROTATING SHAFTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-27 | — | — | WO | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| EP-1649894-A2 | Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials | L'OREAL (FR) | 2006-04-26 | — | — | EP | claimed |
| WO-2006029788-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | claimed |
| US-20060018966-A1 | Antimicrobial mesoporous silica nanoparticles | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2006-01-26 | — | — | US | claimed |
| US-20050287555-A1 | Uses of cationic salts for polynucleotide synthesis | AGILENT TECHNOLOGIES, INC. | 2005-12-29 | — | — | US | claimed |
| EP-1362572-A1 | Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | L'OREAL (FR) | 2003-11-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018966-A1 | Antimicrobial mesoporous silica nanoparticles | MSN, SAAL1, MRPL21 | MEN1 419/4885HSP90AA1 808/4885KMT2A 4338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.